CG Oncology Inc
(NAS:CGON)
$
75.24
+1.89 (+2.58%)
Market Cap: 6.64 Bil
Enterprise Value: 5.57 Bil
PE Ratio: 0
PB Ratio: 6.06
GF Score: 12/100 CG Oncology Inc at Bank of America Global Healthcare Conference Transcript
May 12, 2026 / 05:40PM GMT
Release Date Price:
$72.07
(+3.97%)
Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst
(inaudible) I'm a senior biotech analyst here at Bank of America covering CG Oncology. And thanks for joining us for the session with CG and for joining the 2026 BofA Healthcare Conference. I'm pleased to be joined by Arthur Kuan, the Chairman and Chief Executive Officer of CG; and Ambaw Bellete, President and Chief Operating Officer. Thanks for being here, guys.
Arthur Kuan
CG Oncology Inc - Chairman of the Board, Chief Executive Officer
Thank you. Thanks for having us.
Questions & Answers
Alec Stranahan;Arthur Kuan
Bofa Merrill Lynch Asset Holdings Inc - Analyst;CG Oncology Inc - Chairman of the Board, Chief Executive Officer
Yes. Great. Well, maybe just to tee up the conversation, Arthur, you guys had an update with your 1Q last week. Maybe you can just sort of run through at a high level sort of what was new from that and sort of what investors should be paying attention to over the next few months.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot